TerminatedNot Applicable

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease

Stopped: Endo determined to discontinue its registries and the CURVE registry enrollment has been closed.

United States29 participantsStarted 2023-06-20

Plain-language summary

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Key Inclusion Criteria: * Any adult with a confirmed clinical diagnosis of PD. * Age 18 years (or age of majority in their jurisdiction) or older at time of enrollment. * Willing to participate in the registry (including completion of ePROs) and complete the informed consent form. * Having received PD treatment within 2 weeks before enrollment, at enrollment or any time after the date of enrollment. After a confirmed diagnosis of PD, not having received PD treatment. * Able to participate in English based registry. Key Exclusion criteria: * Not having a clinical diagnosis of PD. * Age less than 18 years. * Do not provide informed consent.

What they're measuring

Number of Participants Receiving Each Treatment Type for PD

Timeframe: Up to 12 months

Trial details

NCT IDNCT05873595

SponsorEndo Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-02-26

View on ClinicalTrials.gov More Peyronie's Disease trials